BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15104897)

  • 1. Modification of alternative splicing by antisense therapeutics.
    Kole R; Vacek M; Williams T
    Oligonucleotides; 2004; 14(1):65-74. PubMed ID: 15104897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA splicing: disease and therapy.
    Douglas AG; Wood MJ
    Brief Funct Genomics; 2011 May; 10(3):151-64. PubMed ID: 21628314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More than a messenger: Alternative splicing as a therapeutic target.
    Black AJ; Gamarra JR; Giudice J
    Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194395. PubMed ID: 31271898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
    Revil T; Shkreta L; Chabot B
    Bull Cancer; 2006 Sep; 93(9):909-19. PubMed ID: 16980234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of pre-mRNA splicing by antisense oligonucleotides.
    Kole R
    Acta Biochim Pol; 1997; 44(2):231-7. PubMed ID: 9360712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of alternative pre-mRNA splicing by RNA Pol II elongation: faster is not always better.
    Nogués G; Kadener S; Cramer P; de la Mata M; Fededa JP; Blaustein M; Srebrow A; Kornblihtt AR
    IUBMB Life; 2003; 55(4-5):235-41. PubMed ID: 12880204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splicing in the immune system: potential targets for therapeutic intervention by antisense-mediated alternative splicing.
    Mourich DV; Iversen PL
    Curr Opin Mol Ther; 2009 Apr; 11(2):124-32. PubMed ID: 19330718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing.
    Peacey E; Rodriguez L; Liu Y; Wolfe MS
    Nucleic Acids Res; 2012 Oct; 40(19):9836-49. PubMed ID: 22844088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense therapeutics: New ways to nudge splicing.
    Eperon I
    Nat Chem Biol; 2012 May; 8(6):507-8. PubMed ID: 22596201
    [No Abstract]   [Full Text] [Related]  

  • 10. Alternative splicing: a new drug target of the post-genome era.
    Hagiwara M
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):324-31. PubMed ID: 16260193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-alpha chain.
    Karras JG; Maier MA; Lu T; Watt A; Manoharan M
    Biochemistry; 2001 Jul; 40(26):7853-9. PubMed ID: 11425312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the circadian clock through pre-mRNA splicing in Arabidopsis.
    Cui Z; Xu Q; Wang X
    J Exp Bot; 2014 May; 65(8):1973-80. PubMed ID: 24604736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression.
    Mercatante DR; Kole R
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):126-32. PubMed ID: 12084454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SR protein kinases: the splice of life.
    Stojdl DF; Bell JC
    Biochem Cell Biol; 1999; 77(4):293-8. PubMed ID: 10546892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of Argonaute proteins on alternative RNA splicing.
    Batsché E; Ameyar-Zazoua M
    Wiley Interdiscip Rev RNA; 2015; 6(1):141-56. PubMed ID: 25255778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor activity of splice-switching oligonucleotides.
    Bauman JA; Li SD; Yang A; Huang L; Kole R
    Nucleic Acids Res; 2010 Dec; 38(22):8348-56. PubMed ID: 20719743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single molecule profiling of alternative pre-mRNA splicing.
    Zhu J; Shendure J; Mitra RD; Church GM
    Science; 2003 Aug; 301(5634):836-8. PubMed ID: 12907803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-mRNA mis-splicing of sarcomeric genes in heart failure.
    Zhu C; Chen Z; Guo W
    Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):2056-2063. PubMed ID: 27825848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.
    Mercatante DR; Sazani P; Kole R
    Curr Cancer Drug Targets; 2001 Nov; 1(3):211-30. PubMed ID: 12188880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of apoptosis by alternative pre-mRNA splicing.
    Schwerk C; Schulze-Osthoff K
    Mol Cell; 2005 Jul; 19(1):1-13. PubMed ID: 15989960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.